NFE2L2/NRF2 silencing-inducible miR-206 targets c-MET/EGFR and suppresses BCRP/ABCG2 in cancer cells.

about

Receptor tyrosine kinases (RTKs) in breast cancer: signaling, therapeutic implications and challenges.MicroRNA profiling associated with muscle growth in modern broilers compared to an unselected chicken breed

P2860

Q49887925-AF382CFA-7F9C-4225-B38D-9B48C4E8A808 Q58732626-A20B12FF-FB1E-40FA-9B10-0C92EF8D6D66

P2860

NFE2L2/NRF2 silencing-inducible miR-206 targets c-MET/EGFR and suppresses BCRP/ABCG2 in cancer cells.

Item

http://www.wikidata.org/entity/Q47111415

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

NFE2L2/NRF2 silencing-inducibl ...... es BCRP/ABCG2 in cancer cells.

@en

NFE2L2/NRF2 silencing-inducibl ...... es BCRP/ABCG2 in cancer cells.

@nl

type

Item

label

NFE2L2/NRF2 silencing-inducibl ...... es BCRP/ABCG2 in cancer cells.

@en

NFE2L2/NRF2 silencing-inducibl ...... es BCRP/ABCG2 in cancer cells.

@nl

prefLabel

NFE2L2/NRF2 silencing-inducibl ...... es BCRP/ABCG2 in cancer cells.

@en

NFE2L2/NRF2 silencing-inducibl ...... es BCRP/ABCG2 in cancer cells.

@nl

P1476

NFE2L2/NRF2 silencing-inducibl ...... es BCRP/ABCG2 in cancer cells.

@en

P2093

Bo-Hyun Choi

http://www.w3.org/2001/XMLSchema#string

Da Young Ryu

http://www.w3.org/2001/XMLSchema#string

In-Geun Ryoo

http://www.w3.org/2001/XMLSchema#string

Mi-Kyoung Kwak

http://www.w3.org/2001/XMLSchema#string

P2860

A multidrug resistance transporter from human MCF-7 breast cancer cells

Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain

MET amplification occurs with or without T790M mutations in EGFR mutant lung tumors with acquired resistance to gefitinib or erlotinib

MicroRNA-1/206 targets c-Met and inhibits rhabdomyosarcoma development

Lapatinib plus capecitabine for HER2-positive advanced breast cancer.

MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling.

Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis

An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements

Epidermal growth factor-induced tumor cell invasion and metastasis initiated by dephosphorylation and downregulation of focal adhesion kinase

Biphasic regulation of the NADPH oxidase by HGF/c-Met signaling pathway in primary mouse hepatocytes

P304

107188-107205

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.22513

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-11-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29291022

http://www.w3.org/2001/XMLSchema#string

P932

5739807

http://www.w3.org/2001/XMLSchema#string

NFE2L2/NRF2 silencing-inducible miR-206 targets c-MET/EGFR and suppresses BCRP/ABCG2 in cancer cells.

about

P2860

P2860

NFE2L2/NRF2 silencing-inducible miR-206 targets c-MET/EGFR and suppresses BCRP/ABCG2 in cancer cells.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P932